MONA NICKERSON: Open Payments
NPI 1154734994 · ADA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,704 in 149 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $160 · 2025 $1,704
Food & beverage: $1,704
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 36 | $401 |
| Neurocrine BioSciences, Inc. | 41 | $349 |
| Teva Pharmaceuticals USA, Inc. | 31 | $333 |
| Janssen Pharmaceuticals, Inc | 15 | $225 |
| Alkermes, Inc. | 12 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $146 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: FANAPT, INGREZZA, INVEGA SUSTENNA, AUSTEDO XR, UZEDY, ARISTADA, CAPLYTA, VIVITROL.
Industry payments across OK — which companies pay providers there.
